Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Global pharma giants turn to Chinese biotech to tap innovation, valuation growth
Global pharmaceutical giants are doubling down on investing in China's fast-growing biotech companies given the sector's huge room for valuation growth, according to speakers at the Global Health Summit, which concluded in Hong Kong on Saturday.
Atyr Pharma: Q2 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.3 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of 11 cents. In the final minutes of…
NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ)
Shares of NRx Pharmaceuticals (NRXP) rose on Friday after the company announced that the FDA didn't identify any major deficiencies as part of an initial review of its marketing application for its preservative-free ketamine product. The regulator…
Wise Equity inks agreement to acquire E-Pharma Trento
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Royalty Pharma (NASDAQ:RPRX) Lowered to 'Buy' Rating by Wall Street Zen
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was downgraded by Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a note issued to investors on Saturday. How Royalty Pharma Prints Cash Without Biotech's Biggest Risks RPRX has been…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $16.85, but opened at $18.49. Ascentage Pharma Group International shares last traded at…
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its price target upped by stock analysts at JPMorgan Chase & Co. from $58.00 to $62.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an 'overweight' rating…
Q1 Results 08th Aug Live: Delhivery, Anant Raj, Apollo Micro Systems, Akums Drugs Pharma, Aditya Birla Fashion, Ceigall India, PNC Infratech Oswal Pumps to announce Q1 results
Q1 Results Today, 08th August 2026 Live Updates: Find all the latest Q1 results 2026 updates of Aditya Birla Fashion and Retail, Akums Drugs and Pharmaceuticals, Anant Raj, Anmol India, Apollo Micro Systems, Delhivery, Eveready Industries India…
Aptar (ATR) Q2 2026 Earnings Call Transcript
Friday, July 31, 2026 at 9:00 a.m. ET President and CEO - Stephan Tanda Executive Vice President and CFO - Vanessa Kanu CEO Designate and President of Aptar Pharma - Gael Touya Senior Vice President, Investor Relations and Communications - Mary…
Ziff Davis expects Q3 revenue down low- to mid-single digits as AI-authored code targets nearly all by end of 2026 (NASDAQ:ZD)
Proceeds will fund tax payments (about $200 million), repay $149 million convertible debt, support ongoing share buybacks, and may be used for potential M&A opportunities. Key risks include declining search referral traffic, increased use of…
Thadi village rehabilitation process set in motion
In a significant development and a major relief for residents of Thadi village, who have been living for years amid pollution from pharmaceutical units in the Jawaharlal Nehru Pharma City (JNPC) at Parawada, the Anakapalli district administration…
Thematic Mutual Funds As Core Holdings? 20 Years Of Rolling Return Data Make a Compelling Case
For years, thematic mutual funds have been viewed as tactical bets rather than long-term investments. The common criticism is that their concentrated portfolios, built around a single theme, are vulnerable to long stretches of underperformance.
Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript
Friday, Jul. 31, 2026 at 7:30 a.m. ET Head of Investor Relations - Adam Uhlman Chief Executive Officer - Patrick Kaltenbach Chief Financial Officer - Shawn Vadala Net Sales -- $1.027 billion, representing a 4% increase on a reported basis or 6% in…
Center's startup scheme is a boon for youngsters: CII Chairman Krishna Mohan
Confederation of Indian Industries-Visakhapatnam Chairman G.Krishna Mohan on Friday that the Union government's Startup India Seed Fund Scheme would help youngsters to launch their own Startups and implement their innovation ideas very quickly.
Fortrea (FTRE) Q2 2026 Earnings Call Transcript
Wednesday, July 29, 2026 at 8 a.m. ET Chief Executive Officer - Anshul Thakral Interim Chief Financial Officer - David Smith Senior Vice President, Investor Relations - Tracy Krumme Former Chief Financial Officer - Jill McConnell Revenue -- $678.2…
Receive a Daily briefing on Pharma Industry News
Get Started